Emerging immune targets for the therapy of allergic asthma

David B. Corry

doi:10.1038/nrd702

Emerging immune targets for the therapy of allergic asthma

David B. Corry

Research Institute

Research output: Contribution to journal › Review article › peer-review

44 Scopus citations

Abstract

Recent discoveries on the molecular and cellular basis of asthma have markedly altered our understanding of this common respiratory disorder. These insights have come during an unexplained period of rising disease incidence and severity and are now being applied to develop improved therapies. This review explores the latest advances in our understanding of the pathogenesis of allergic asthma, and provides insight into the expanding collaborations between research scientists, clinicians and the pharmaceutical industry in the race to control the asthma epidemic.

Original language	English (US)
Pages (from-to)	55-64
Number of pages	10
Journal	Nature Reviews Drug Discovery
Volume	1
Issue number	1
DOIs	https://doi.org/10.1038/nrd702
State	Published - Jan 2002

ASJC Scopus subject areas

Pharmacology
Drug Discovery

Access to Document

10.1038/nrd702

Cite this

@article{f317d0dd090c42b6b94b75eaa61b5958,

title = "Emerging immune targets for the therapy of allergic asthma",

abstract = "Recent discoveries on the molecular and cellular basis of asthma have markedly altered our understanding of this common respiratory disorder. These insights have come during an unexplained period of rising disease incidence and severity and are now being applied to develop improved therapies. This review explores the latest advances in our understanding of the pathogenesis of allergic asthma, and provides insight into the expanding collaborations between research scientists, clinicians and the pharmaceutical industry in the race to control the asthma epidemic.",

author = "Corry, {David B.}",

year = "2002",

month = jan,

doi = "10.1038/nrd702",

language = "English (US)",

volume = "1",

pages = "55--64",

journal = "Nature Reviews Drug Discovery",

issn = "1474-1776",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Emerging immune targets for the therapy of allergic asthma

AU - Corry, David B.

PY - 2002/1

Y1 - 2002/1

N2 - Recent discoveries on the molecular and cellular basis of asthma have markedly altered our understanding of this common respiratory disorder. These insights have come during an unexplained period of rising disease incidence and severity and are now being applied to develop improved therapies. This review explores the latest advances in our understanding of the pathogenesis of allergic asthma, and provides insight into the expanding collaborations between research scientists, clinicians and the pharmaceutical industry in the race to control the asthma epidemic.

AB - Recent discoveries on the molecular and cellular basis of asthma have markedly altered our understanding of this common respiratory disorder. These insights have come during an unexplained period of rising disease incidence and severity and are now being applied to develop improved therapies. This review explores the latest advances in our understanding of the pathogenesis of allergic asthma, and provides insight into the expanding collaborations between research scientists, clinicians and the pharmaceutical industry in the race to control the asthma epidemic.

UR - http://www.scopus.com/inward/record.url?scp=0036051993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036051993&partnerID=8YFLogxK

U2 - 10.1038/nrd702

DO - 10.1038/nrd702

M3 - Review article

C2 - 12119610

AN - SCOPUS:0036051993

VL - 1

SP - 55

EP - 64

JO - Nature Reviews Drug Discovery

JF - Nature Reviews Drug Discovery

SN - 1474-1776

IS - 1

ER -

Emerging immune targets for the therapy of allergic asthma

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this